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Abstract
Exposure to ultraviolet-B (UVB) radiation induces inflammation and photocarcinogenesis in mammalian skin.
Docosahexaenoic acid (DHA), a representative v-3 polyunsaturated fatty acid, has been reported to possess anti-
inflammatory and chemopreventive properties. In the present study, we investigated the molecular mechanisms underlying
the inhibitory effects of DHA on UVB-induced inflammation in mouse skin. Our study revealed that topical application of
DHA prior to UVB irradiation attenuated the expression of cyclooxygenase-2 (COX-2) and NAD(P)H:oxidase-4 (NOX-4) in
hairless mouse skin. DHA pretreatment also attenuated UVB-induced DNA binding of nuclear factor-kappaB (NF-kB) through
the inhibition of phosphorylation of IkB kinase-a/b, phosphorylation and degradation of IkBa and nuclear translocation of
p50 and p65. In addition, UVB-induced phosphorylation of p65 at the serine 276 residue was significantly inhibited by
topical application of DHA. Irradiation with UVB induced phosphorylation of mitogen and stress-activated kinase-1 (MSK1),
extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein (MAP) kinase, and all these events were
attenuated by pretreatment with DHA. Blocking ERK and p38 MAP kinase signaling by U0126 and SB203580, respectively,
diminished MSK1 phosphorylation in UVB-irradiated mouse skin. Pretreatment with H-89, a pharmacological inhibitor of
MSK1, abrogated UVB-induced activation of NF-kB and the expression of COX-2 and NOX-4 in mouse skin. In conclusion,
topically applied DHA inhibits the UVB-induced activation of NF-kB and the expression of COX-2 and NOX-4 by blocking the
phosphorylation of MSK1, a kinase downstream of ERK and p38 MAP kinase, in hairless mouse skin.
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Introduction
Ultraviolet B (UVB) radiation is the most prevalent environmen-
tal carcinogen that increases the risk of skin cancer [1]. Oxidative
stress and persistent inflammation are the key pathologic events in
UVB-induced skin photocarcinogenesis [2]. NAD(P)H:oxidases
(NOX), a family of inducible membrane bound and cytosolic
enzymes, is involved in the generation of reactive oxygen species
(ROS) [3].Theexpression and activityofdifferentisoformsofNOX
are elevated in various human cancers [4,5]. NOX-4, a member of
the NOX family proteins, is an oncoprotein [6] that contributes to
the transformation, proliferation and migration of cancer cells [7,8].
Although NOX is involved in UVB-induced generation of ROS in
human keratinocytes [9], it is yet to be investigated if UVB irradia-
tion can induce NOX-4 expression in mouse skin in vivo.
Cyclooxygenase-2 (COX-2), a rate limiting enzyme in the
biosynthesis of prostaglandins, has been implicated in carcinogen-
esis [10]. Elevated expression of COX-2 has been documented in
hyperplastic skin, benign papillomas and squamous cell carcinomas
of UVB-irradiated mouse skin [11]. The increased susceptibility of
cox-2 transgenic mice to chemically induced skin papillomagenesis
[12] and the reduced incidence and the multiplicity of skin tumors
in cox-2 knockout mice support the role of COX-2 in skin carcino-
genesis [13]. Moreover, pharmacological inhibition of COX-2
protected against UVB-induced mouse skin tumorigenesis [14].
Notably, UVB irradiation induces the expression of COX-2 in
mouse skin through inappropriate amplification of cell signaling
pathways consisting of various kinases and their downstream
transcription factors [15,16,17].
Nuclear factor-kappaB (NF-kB), a heterodimer of p65 and p50
proteins, is a redox-sensitive transcription factor which plays a key
role in COX-2 expression in mouse skin uponirradiation withUVB
[18]. Exposure to UVB radiation leads to the phosphorylation of
mitogen-activated protein (MAP) kinases, such as extracellular
signal-regulated kinase (ERK) [19] and p38 MAP kinase [15,17],
which activates NF-kB and induces COX-2 expression [20]. The
activation of p38 MAP kinase and NF-kB is also involved in the
induction of NOX-4 expression in c-radiation-stimulated lung
fibroblasts [21] and tumor necrosis factor-a (TNFa)-treated human
aortic smooth muscle cells [22], respectively. A common substrate
for ERK and p38 MAP kinase is mitogen- and stress-activated
kinase-1 (MSK1), which transmits signals down to NF-kBi n
hydrogen peroxide-stimulated skeletal myoblasts [23]. However,
the role of MSK1 in UVB-irradiated mouse skin inflammationis yet
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28065to be investigated. This prompted us to examine the role of MSK1
in the UVB-induced activation of NF-kB and expression of COX-2
and NOX-4 in mouse skin.
Since COX-2 and NOX-4 play important roles in inducing
oxidative stress and inciting inflammation, targeted inhibition
of signaling pathways associated with the aberrant expression of
these proteins would be a rational approach for chemoprevention
[24]. Docosahexaenoic acid (DHA), a representative v-3 polyun-
saturated fatty acid abundantly present in fish oil and some
plant seed oils, possesses antioxidative, anti-inflammatory and
chemopreventive properties [25]. However, the effects of DHA on
UVB-induced mouse skin inflammation and its underlying
molecular mechanisms have not been investigated yet. Here, we
report that topical application of DHA inhibits UVB-induced
expression of COX-2 and NOX-4 in mouse skin by blocking the
activation of NF-kB through the inhibition of ERK- and p38 MAP
kinase-mediated phosphorylation of MSK1.
Results
DHA inhibits UVB-induced expression of COX-2 and
NOX-4 in HR-1 hairless mouse skin
The expression of COX-2 is transiently induced by diverse
stimuli including exposure to UVB radiation [15,18]. We have
previously reported that irradiation with UVB (180 mJ/cm
2)
induces COX-2 expression in HR-1 hairless mouse skin maximally
at 6 h [26]. In the present study, pretreatment with DHA (2.5 or
10 mmol) significantly attenuated UVB-induced COX-2 expression
in mouse skin at 6 h post-irradiation (Fig. 1A). Immunohistochem-
ical analysis further confirmed the inhibitory effect of DHA on
UVB-induced epidermal COX-2 expression (Fig. 1B). Further
analysis of immunohistochemical data revealed that DHA signifi-
cantly decreased the proportion of epidermal cells expressing COX-
2. NOX-4, a superoxide generating enzyme, is an oncoprotein [6]
that is overexpressed in melanoma cells [8]. We examined the
Figure 1. Inhibitory effects of DHA on UVB-induced expression of COX-2 and NOX-4 in mouse skin. Dorsal skin of female HR-1 hairless
mice (n=3 per treatment group) were treated topically with DHA (2.5 or 10 mmol/mouse) dissolved in 0.2 ml acetone 40 min before UVB (180 mJ/
cm
2) irradiation, and sacrificed after 6 h. Control animals were treated with acetone and left unirradiated. (A) Epidermal lysates were analyzed for
COX-2 expression by immunoblotting. *, p,0.001 (control versus UVB); **, p,0.01 (UVB only versus 2.5 or 10 mmol DHA plus UVB). (B) Skin samples
from mice treated as above were subjected to immunohistochemical analysis by using affinity purified murine COX-2 antibody as described in
Materials and Methods. Positive COX-2 staining yielded a brown-colored product: acetone (left), UVB alone (middle), and UVB plus 10 mmol DHA
(right). Percent of COX-2 positivity was calculated as the ratio of number of COX-2-stained cells to total number of epidermal cells counted from 10
equal sections of immunostained tissues from each animal. *, p,0.001 (control versus UVB); **, p,0.01(UVB versus 10 mmol DHA plus UVB). (C)
Dorsal skin was irradiated with UVB and animals were sacrificed at indicated time periods for assessing NOX-4 expression. *, p,0.001 (control versus
UVB). (D) Mice were treated with DHA and irradiated with UVB as indicated above and epidermal NOX-4 expression was examined by
immunoblotting. *, p,0.001 (control versus UVB); **, p,0.01 (UVB alone versus 2.5 mmol DHA plus UVB); ***, p,0.001 (UVB alone versus 10 mmol
DHA plus UVB).
doi:10.1371/journal.pone.0028065.g001
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Fig. 1C, exposure to UVB radiation induced NOX-4 expression
in HR-1 hairless mouse skin in a time-dependent fashion with
maximum induction at 6 h post-irradiation. Topical application of
DHA onto mouse skin prior to UVB irradiation significantly
reduced NOX-4 expression (Fig. 1D).
DHA attenuates UVB-induced activation of NF-kBi n
hairless mouse skin
The promoter region of murine cox-2 gene harbors binding sites
for NF-kB [27]. Moreover, the transcriptional activation of NOX-
4 is regulated in part by NF-kB in TNFa-stimulated human aortic
smooth muscle cells [22]. We have previously reported that UVB
radiation activates NF-kB in hairless mouse skin at 1 h which
persists until 6 h post-irradiation [19]. Since NF-kB is involved in
the transcriptional activation of COX-2 [27] and NOX-4 [22],
we examined the effect of DHA on NF-kB activation in UVB-
irradiated hairless mouse skin. As illustrated in Fig. 2A, pretreat-
ment with DHA (2.5 or 10 mmol) inhibited UVB-induced DNA
binding of NF-kB in mouse skin. Topical application of DHA
significantly diminished the phosphorylation and degradation of
IkBa (Fig. 2B), phosphorylation of IKKa/b (Fig. 2C), and
subsequent nuclear translocation of p65 and p50 proteins
(Fig. 2D) in UVB-irradiated mouse skin.
DHA inhibits phosphorylation of MSK1 by blocking the
activation of ERK and p38 MAP kinase in UVB-irradiated
mouse skin
A panel of upstream serine/theronine kinases transmit activat-
ing signal to NF-kB. MSK1 is a serine/threonine kinase known to
induce NF-kB activation in response to diverse stimuli, such as
interleukin-1b (IL-1b) [28] and TNFa [29]. Moreover, MSK1 is a
substrate for ERK and p38 MAP kinase [23], which regulate
UVB-induced activation of NF-kB in keratinocytes [30] and in
SKH hairless mouse skin [31]. However, it is yet to be examined if
MSK1 is phosphorylated in mouse skin upon UVB exposure. We
found that exposure of HR-1 hairless mouse skin to UVB radiation
led to the phosphorylation of MSK1 (threonine 581) at 1 h
(Fig. 3A, Fig. S1A). The UVB-induced phosphorylation of MSK1
was inhibited by pretreatment with H-89, a pharmacological
inhibitor of MSK1 (Fig. 3B, Fig. S1B). Pretreatment with DHA
also diminished UVB-induced phosphorylation of MSK1 in
mouse skin as revealed by immunoblot (Fig. 3C, Fig. S1C) as
well as immunohistochemical analyses (Fig. 3D). We also found
that exposure to UVB radiation induced the phosphorylation of
ERK and p38 MAP kinase in mouse skin at 1 h post irradiation
(Fig 3E, Fig. S1D), and this was attenuated by pretreatment with
DHA (Fig. 3F, Fig. S1E). Topical application of H-89 at a dose of
25 nmol that inhibited MSK1 phosphorylation failed to diminish
UVB-induced phosphorylation of ERK and p38 MAP kinase
(Fig. 3G, Fig. S1F). On the other hand, pretreatment with U0126
(5 mmol) and SB203580 (5 mmol), pharmacological inhibitors of
ERK and p38 MAP kinase, respectively, attenuated UVB-induced
MSK1 phosphorylation in mouse skin (Fig. 3H).
A role of MSK1 in UVB-induced activation of NF-kBi n
mouse skin and its modulation by DHA
We examined whether pharmacological inhibition of MSK1
could suppress the activation of NF-kB in HR-1 hairless mouse
skin. Irradiation of dorsal skin of hairless mice with UVB induced
the DNA binding of NF-kB, which was abrogated by pretreatment
with H-89 (Fig. 4A). H-89 (25 nmol) also inhibited UVB-induced
phosphorylation and subsequent degradation of IkBa (Fig. 4B),
but failed to inhibit phosphorylation of IKKa/b (Fig. S2). In
addition, treatment of mouse skin with H-89 attenuated nuclear
translocation of p50 and p65/RelA in UVB-irradiated mouse skin
(Fig. 4C). The phosphorylation of p65 at the serine 276 residue in
UVB-irradiated mouse skin was also inhibited by pretreatment
with either H-89 (Fig. 4D) or DHA (Fig. 4E).
Involvement of MSK1 in UVB-induced expression of
COX-2 and NOX-4 in mouse skin
To determine the possible role of MSK1 in UVB-induced
expression of COX-2 and NOX-4, we measured the expression of
these proteins in UVB-irradiated mouse skin pretreated with H-
89. As shown in Fig. 5A, topical application of H-89 (25 nmol/
mouse) 40 min prior to UVB irradiation diminished the expression
of COX-2 in mouse skin. Immunohistochemical analysis of COX-
2 expression in mouse skin irradiated with UVB in the presence or
absence of H-89 confirmed the inhibitory effect of H-89 on UVB-
induced COX-2 expression (Fig. 5B). Pretreatment with H-89 also
abolished NOX-4 expression (Fig. 5C) in UVB-irradiated mouse
skin.
Discussion
The health beneficial effects of v-3 polyunsaturated fatty acids,
in particular DHA, have been well demonstrated in a wide range
of population-based and laboratory studies [32]. However, the
molecular mechanisms underlying its anti-oxidative and anti-
inflammatory activities have not been fully clarified. Solar
radiation, particularly UVB, induces oxidative stress and inflam-
mation in skin [2]. Aberrant expression of NOX [33] and COX-2
[34] plays a key role in inducing oxidative stress and inflammation.
Thus, inhibition of NOX and COX-2 expression can protect
against oxidative and inflammatory tissue damages, and hence can
prevent carcinogenesis [24]. In the present study, we sought to
examine the effect of UVB on the expression of COX-2 and
NOX-4 in hairless mouse skin, and its possible modulation by
DHA.
NOX comprises a group of enzymes, either membrane-bound
or cytosolic, which mediates generation of ROS by diverse
external stimuli [21]. Constitutive expression of NOX-1, NOX-2
and NOX-4 has been reported in human keratinocytes (HaCaT)
[35]. Pharmacological inhibition of NOX inhibits phorbol ester-
induced activation of p53 and induction of apoptosis in 7,12-
dimethylbenz[a]anthracene-treated mouse skin [36]. However,
little is known about the mechanism and consequences of NOX
expression in mouse skin upon UVB exposure. Our study has
revealed that the expression of NOX-4, one isoform of NOX
enzymes, has been elevated in UVB-irradiated mouse skin as early
as 1 h and persists until 6 h post-irradiation. NOX-4 has been
reported to be induced by other stimuli, such as hypoxia [37],
urotensin-II [38], transforming growth factor-b1 [39], angiotensin-
II (Ang-II) [40] and TNFa [41]. The effect of UVB radiation on
the expression of other isoforms of NOX in mouse skin merits
further investigation. While the molecular mechanisms underlying
UVB-induced NOX-4 expression have not been investigated
earlier, UVB-induced COX-2 expression involves inappropriate
amplification of cell signaling pathways comprising MAP kinases
and redox-regulated transcription factors [15,17].
DHA has been reported to inhibit NOX-4 expression in
cultured cells stimulated with several stimuli other than UVB [42].
Our study provides the first demonstration that DHA can inhibit
UVB-induced NOX-4 expression in mouse skin in vivo. The
inhibitory effect of DHA on UVB-induced COX-2 expression in
mouse skin is well correlated with several previous studies. It has
Docosahexaenoic Acid Inhibition of COX-2 and NOX-4
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stimulated keratinocytes [43]. An et al. also demonstrated that
supplementation with DHA inhibited COX-2 expression in rat
kidney undergoing partial nephroctomy [44]. In contrast, DHA
enhanced phorbol ester- or IL-1b-induced COX-2 expression in
rat vascular endothelial cells [45]. The opposing effects of DHA on
COX-2 expression may be due to the stimulus- and cell type-
specific response of the compound.
The presence of NF-kB-responsive cis-acting elements in the
promoter regions of COX-2 [27] and NOX-4 [22] genes led us to
examine the effects of DHA on UVB-induced NF-kB activation in
hairless mouse skin. NF-kB, predominantly a heterodimer of p50
and p65 proteins, is normally sequestered in the cytoplasm by
forming an inactive complex with the inhibitory protein IkBa
[46]. Irradiation with UVB induced the phosphorylation of IKK
and IkBa [19] and the induction of NF-kB [19] in hairless mouse
Figure 2. DHA inhibits UVB-induced activation of NF-kB in mouse skin. Female HR-1 hairless mice (n=3 per treatment group) were treated
topically with DHA (2.5 or 10 mmol/mouse) dissolved in 0.2 ml acetone. After 40 min, animals were exposed to UVB radiation (180 mJ/cm
2). Control
animals were treated with acetone and were not exposed to UVB. Animals were sacrificed 1.5 h post-UVB irradiation. The epidermal nuclear extract
was prepared as described in Materials and Methods and analyzed by the EMSA. (A) Effects of DHA on UVB-induced NF-kB DNA binding.
Representative data showing probe only (lane 1), vehicle control (lane 2), UVB alone (lane 3), 2.5 mmol DHA plus UVB (lane 4), 10 mmol DHA plus UVB
(lane 5), and nuclear extract from UVB-treated skin plus 100-fold excess unlabeled NF-kB oligonucleotide (lane 6). *, p,0.001 (vehicle only versus
UVB); **, p,0.01 (UVB versus 2.5 mmol DHA plus UVB); ***, p,0.001 (UVB versus 10 mmol DHA plus UVB). (B) Cytosolic extract was prepared as
described in Materials and Methods and subjected to Western blot analysis to determine the expression of total and phosphorylated IkBa. *, p,0.001
(control versus UVB); **, p,0.001 (UVB versus 10 mmol DHA plus UVB). (C) Epidermal lysate was analyzed for phosphorylation of IKKa/b (serine 181)
by immunoblot analysis. *, p,0.001 (control versus UVB); **, p,0.001 (UVB versus 10 mmol DHA plus UVB). (D) Epidermal nuclear extract was
assayed for nuclear localization of p50 and p65. *, p,0.001 (control versus UVB); **, p,0.05 (UVB versus 2.5 mmol DHA plus UVB); ***, p,0.001 (UVB
versus 10 mmol DHA plus UVB).
doi:10.1371/journal.pone.0028065.g002
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UVB-induced DNA binding of NF-kB, phosphorylation of IKKa/
b, phosphorylation and degradation of IkBa, and nuclear
localization of p50 and p65 proteins are in good agreement with
the inhibitory effects of DHA on NF-kB activation in cultured cells
exposed to stimuli other than UVB (53, 54). DHA has been shown
to inhibit NF-kB activation in TNFa-treated human aortic
endothelial cells [47] and lipopolysaccharide (LPS)-stimulated
THP-1-derived macrophages [48]. Besides NF-kB, the transcrip-
tional activation of NOX-4 [49] and COX-2 [50] is regulated by
signal transducer and activator of transcription (STAT). Whether
DHA can inhibit UVB-induced activation of STAT signaling as a
Figure 3. DHA inhibits UVB-induced phosphorylation of MSK1 by blocking ERK and p38 MAP kinase in mouse skin. (A,E) Mice (n=3
per group) were irradiated with UVB (180 mJ/cm
2) and sacrificed at indicated time periods. (A) Tissue lysates were separated by 10% SDS-
polyacrylamide gel, transferred to PVDF membrane and immunoblotted to detect the expression of phosphorylated (threonine 581) MSK1. Figure
S1A represents the statistical analysis of image density of UVB-induced expression of phospho-MSK1. (B–D, F–H) Animals were treated topically with
H-89 (25 or 100 nmol/mouse), DHA (2.5 or 10 mmol/mouse), U0126 (5 mmol/mouse) or SB203580 (5 mmol/mouse) 40 min before exposure to UVB
and were sacrificed 1.5 h post-irradiation. (B) Epidermal lysates from mice irradiated with UVB in presence or absence of H-89 (25 or 100 nmol/
mouse) were immunoblotted for detecting the expression of MSK1 and phospho-MSK1. Figure S1B represented the densitometric analysis of
immunoblots. (C) Epidermal protein extracts from mice irradiated with UVB with or without pretreatment with DHA (2.5 or 10 mmol) were subjected
to Western blot analysis to detect the expression of MSK1 and pMSK1 (threonine 581). Figure S1C illustrated the quantification of band intensity of
phospho-MSK1. (D) Immunohistochemical analysis of pMSK1 expression in mouse epidermis upon irradiation with UVB in presence or absence of
DHA. (E) Epidermal lysates were subjected to Western blot analysis to examine the expression of phosphorylated ERK and p38 MAP kinase upon UVB
irradiation. Quantification and statistical analysis of immunoblots were presented in Figure S1D.( F) Inhibitory effects of DHA on UVB-induced
phosphorylation of ERK and p38 MAP kinase. Figure S1E represents the quantification data of phospho-ERK and phospho-p38 MAP kinase. (G)
Effect of H-89 on the phosphorylation of ERK and p38 MAP kinase in UVB-irradiated mouse skin. Assessment of relative band intensity was presented
in Figure S1F.( H) Skin samples from mice pretreated with SB203580 or U0126 (each 5 mmol in 0.2 ml acetone) and irradiated with UVB were
subjected to immunohistochemical analysis. Positive phospho-MSK1 staining yielded a brown-colored product.
doi:10.1371/journal.pone.0028065.g003
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of COX-2 and NOX-4 in mouse skin needs additional
investigation.
UVB irradiation induces phosphorylation of several upstream
kinases, such as ERK [26], p38 MAP kinase [17] and Akt [15]
in mouse skin. Activation of these upstream kinases leads to
the amplification of NF-kB-mediated signaling and aberrant
expression of COX-2 [20]. The inhibitory effects of DHA on
UVB-induced phosphorylation of ERK and p38 MAP kinase,
thus, provide a mechanistic basis of this v-3 polyunsaturated fatty
acid in suppressing COX-2 expression and NF-kB activation in
mouse skin.
The inhibition of ERK has been shown to diminish NOX-4
expression in human aortic endothelial cells [42] and human
Figure 4. Inhibitory effect of DHA on UVB-induced activation of NF-kB is mediated through inhibition of MSK1. Mice (n=3 per
treatment group) were treated topically with H-89 (25 nmol) or DHA (10 mmol) as described in figure 2 and sacrificed 1.5 h later. (A) Nuclear protein
(10 mg) was subjected to EMSA to examine the effect of H-89 or DHA on UVB-induced DNA binding of NF-kB. *, p,0.001 (control versus UVB);
**, p,0.01 (UVB versus 10 mmol DHA plus UVB); ***, p,0.001 (UVB versus 25 nmol H-89 plus UVB). (B) Inhibitory effects of H-89 or DHA on UVB-
induced phosphorylation of IkBa was measured by immunoblot analysis. *, p,0.001 (control versus UVB); **, p,0.01 (UVB versus 10 mmol DHA plus
UVB); ***, p,0.001 (UVB versus 25 nmol H-89 plus UVB). (C) Nuclear extracts were analyzed by western blotting for nuclear translocation of p50 and
p65. *, p,0.001 (control versus UVB); **, p,0.01 (UVB versus 10 mmol DHA or 25 nmol H-89 plus UVB). (D) Dorsal skin of HR-1 hairless mice was
treated topically with H-89 (25 nmol/mouse) followed by irradiation with UVB to detect the phosphorylation of NF-kB p65 (serine-276). *, p,0.001
(control versus UVB); **, p,0.001 (UVB versus 25 nmol H-89 plus UVB). (E) Epidermal lysates from mice pretreated with DHA (2.5 or 10 mmol/mouse)
and irradiated with UVB were subjected to western blotting analysis to determine the phosphorylation of NF-kB p65 (serine-276). *, p,0.001 (control
versus UVB); **, p,0.001 (UVB versus 10 mmol DHA plus UVB). Figure S2, represents the effect of H-89 on UVB-induced phosphorylation of IKKa/b
(Ser 181).
doi:10.1371/journal.pone.0028065.g004
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oxidized low density lipoprotein, respectively. In addition,
transient overexpression of p65 induces the NOX-4 promoter
activity in human aortic endothelial cells [22]. Thus, the
inactivation of ERK and NF-kB signaling by DHA may partly
account for its inhibition of UVB-induced NOX-4 expression.
Whether the expression of NOX-4 in UVB-irradiated mouse skin
is directly regulated by ERK and NF-kB is yet to be investigated.
Several studies have demonstrated that MSK1 functions as a
signaling molecule downstream of ERK and p38 MAP kinase
[23,52]. Moreover, MSK1 plays a critical role in activating NF-kB
through phosphorylation of p65 at the serine 276 residue [53].
Although MSK1 is phosphorylated at multiple sites, phosphory-
lation at the threonine 581 residue is essential for its catalytic
activity [52]. We found that UVB irradiation induced phosphor-
ylation of MSK1 at threonine 581 in mouse skin and that the
treatment with DHA inhibited MSK1 phosphorylation. Treat-
ment with H-89 failed to block phosphorylation of ERK and p38
MAP kinase, while U0126 and SB203580 attenuated phosphor-
ylation of MSK1. These findings suggest that MSK1 acts as a
downstream signaling molecule to ERK and p38 MAP kinase in
UVB-irradiated mouse skin. We attempted to elucidate the role of
MSK1 in the activation of NF-kB and subsequent expression of
COX-2 and NOX-4 in mouse skin. The inhibition of the
phosphorylation of IkBa nuclear localization of p50 and p65
phosphorylation of p65 and the DNA binding of NF-kBb y
pretreatment with H-89 suggest that MSK1 is a critical signaling
molecule in UVB-induced activation of NF-kB in mouse skin.
Moreover, the inhibitory effect of H-89 on UVB-induced NOX-4
and COX-2 expression indicates that MSK1 plays an important
role in UVB-induced oxidative stress and inflammation in mouse
skin.
As an ROS-generating enzyme NOX-4 may contribute to the
activation of MAP kinases and NF-kB. Sedeek et al. demonstrated
that the treatment of mouse proximal tubular cells with D-glucose
induced the expression of NOX-4 and increased the phosphor-
ylation of p38 MAP kinase. Inhibition of NOX-4 by GKT136901
abrogated D-glucose-induced p38 MAP kinase phosphorylation
[54]. The induction of NOX-4 is also essential for LPS-induced
activation of NF-kB in human embryonic kidney (HEK293T) cells
[55]. Our observation that NOX-4 was induced in mouse skin at 1
h post-UVB irradiation raises the possibility that NOX-4
induction may contribute to UVB-induced activation of MAP
kinases and NF-kB. However, the inhibition of UVB-induced
phosphorylation of ERK and p38 MAP kinase and activation of
NF-kB by DHA in mouse skin is unlikely to be mediated through
Figure 5. Role of MSK1 in UVB-induced expression of COX-2 and NOX-4 in mouse skin. Animals were treated topically with H-89
(25 nmol) or DHA (10 mmol) as described in Fig. 1 and sacrificed 6 h post irradiation. (A) Effect of H-89 or DHA on UVB-induced COX-2 expression was
analyzed by Western blot analysis. *, p,0.001 (control versus UVB); **, p,0.01 (UVB versus 10 mmol DHA plus UVB); ***, p,0.01 (UVB versus
25 nmol H-89 plus UVB). (B) Formalin-fixed skin tissues pretreated with H-89 and exposed to UVB radiation were subjected to immunohistochemical
analysis. Positive COX-2 staining yielded a brown-colored product: acetone (left), UVB alone (middle), and UVB plus H-89, 25 nmol (right). Percent of
COX-2 positivity in epidermal layer was determined by counting the number of total COX-2 positive cells from 10 equal sections of immunostained
tissues from each animal. *, p,0.001 (control versus UVB); **, p,0.01 (UVB versus 25 nmol H-89 plus UVB). (C) Cell lysates were analyzed for NOX-4
by using western blotting. *, p,0.001 (control versus UVB); **, p,0.01 (UVB versus 10 mmol DHA plus UVB); ***, p,0.01 (UVB versus 25 nmol H-89
plus UVB).
doi:10.1371/journal.pone.0028065.g005
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with DHA failed to inhibit UVB-induced NOX-4 expression at
1.5 h (data not shown), the time when DHA attenuated the
activation of aforementioned MAP kinases and NF-kB.
Several studies have demonstrated that DHA undergoes enzy-
matic conversion by acetylated-COX-2 and 5-lipoxygenases (5-
LOX) that generates a series of proresolving mediators responsible
for early resolution of inflammation [56,57]. We observed that
DHA attenuated the activation of MAP kinases and NF-kB
after UVB exposure for 1.5 h, the time when COX-2 was not
induced in mouse skin (data not shown). 5-LOX is also an
inducible enzyme that is expressed in human dermal fibroblasts
after 24-h UVB exposure [58]. Thus, the inhibitory effect of DHA
on UVB-induced expression of NOX-4 and COX-2 is unlikely to
be mediated by its metabolites.
In conclusion, our study demonstrates that topical application of
DHA protects against UVB-induced oxidative stress and inflam-
mation through inactivation of NF-kB and downregulation of
the upstream MSK1 signaling, which provides a mechanistic
basis of anti inflammatory effects of DHA in mouse skin in vivo.
Since oxidative stress and inflammation trigger tumor promotion,
this study signifies the potential of DHA in preventing skin
photocarcinogenesis.
Materials and Methods
Ethical statement
All experimental protocols were approved by the Animal Care
and Use Committee (ACUC) of Seoul National University, South
Korea (permit number: SNU-100504-3).
Materials
DHA (purity.98%) was purchased from Cayman Chemical
Co. (Ann Arbor, MI, USA). H-89, a pharmacological inhibitor of
MSK1, was brought from Sigma-Aldrich (St Louis, MO, USA).
U0126 and SB203580, selective inhibitors of ERK and p38 MAP
kinase respectively, were procured from Tocris Bioscience
(Ellisville, MO, USA). Primary antibodies for NOX-4, p65, p50,
IkBa, pIKKa/b, ERK, pERK, p38, and MSK1 were supplied by
Santa Cruz Biotechnology (Santa Cruz, CA, USA) and phospho-
p65 (serine 276), pMSK1 (threonine 581) were procured from Cell
Signaling Technology (Beverly, MA, USA). Antibodies for COX-2
and p38 MAP kinase were from Cayman Chemical Co. (Ann
Arbor, MI, USA) and BD Bio-science Laboratories (San Jose, CA,
USA), respectively. Anti-actin antibody was obtained from Sigma
Chemical Company (St. Louis, MO, USA). Anti-rabbit and anti-
mouse horseradish peroxidase-conjugated secondary antibodies
were obtained from Zymed Laboratories Inc. (San Francisco, CA,
USA). Enhanced chemiluminescent (ECL) detection kit and
[c-
32P]ATP were purchased from Amersham Pharmacia Biotech
(Buckinghamshire, UK). Oligonucleotide probe containing the
NF-kB consensus sequence in mouse COX-2 promoter region was
purchased from Promega (Madison, WI, USA). All other
chemicals used were in the purest form available commercially.
Animal treatment
Female HR-1 hairless mice (6–7 weeks age) were supplied from
Sankyo Laboservice Corporation, Inc. (SLC, Tokyo, Japan).
Animals were housed in climate-controlled quarters (2461uCa t
50% humidity) with a 12-h light/12-h dark cycle. DHA (2.5 and
10 mmol) was dissolved in 200 ml of acetone and applied topically
to the dorsal skin 40 min before exposure to UVB (180 mJ/cm
2)
radiation.
Source of UVB radiation
The source of UVB radiation was a 568 Watt tube, which emits
an energy spectrum with high fluency in the UVB region (with a
peak at 312 nm). A Biolink BLX-312 UV crosslinker (Vilbert
Lourmat, Marne-la-Vale ´e, France) was used in the present study
to irradiate mouse skin.
Western blot analysis
Dorsal skin of HR-1 hairless mice were treated with DHA (2.5
or 10 mmol/mouse), H-89 (25 or 100 nmol/mouse), SB203580
(5 mmol/mouse) or U0126 (5 mmol/mouse) 40 min before expo-
sure to UVB (180 mJ/cm
2) and sacrificed by cervical dislocation
either 1.5 or 6 h later. Control animals were treated with vehicle
only. For the preparation of mouse epidermal protein extract, fat
and dermis were removed from the harvested skin samples by
keeping on ice, and the fat-free epidermis was immediately placed
in liquid nitrogen and pulverized in mortar. The pulverized
skin was homogenized on ice for 20 s with a polytron tissue
homogenizer and lysed in 1 ml ice-cold lysis buffer (150 mM
NaCl, 0.5% Triton X-100, 50 mM Tris-HCl pH 7.4, 20 mM
EGTA, 1 mM dithiothreitol, 1 mM Na3VO4 and protease
inhibitor cocktail tablet). Lysates were centrifuged at 14,800 x g
for 15 min. The supernatant was collected and total protein
concentration was quantified by using the bicinchoninic acid
(BCA) protein assay kit. Cell lysates (30 to 50 mg protein) were
boiled in sodium dodecyl sulfate (SDS) sample loading buffer for
5 min before electrophoresis on 10–12% SDS-polyacrylamide gel.
After transfer to polyvinylidene difluoride membrane, the blots
were blocked with 5% fat-free dry milk-PBST (phosphate-buffer
saline containing 0.1% Tween 20) or 1% BSA in TBST (Tris-
buffer saline containing 0.1% Tween 20) for 1 h at room
temperature and then washed with PBST or TBST buffer. The
membranes were incubated for 2 h at room temperature with
1:1000 dilutions of primary antibodies for actin, ERK and p38,
for 12 h at 4uC with 1:1000 dilutions of primary antibodies for
phospho-p38, phospho-ERK, IkBa, phospho-IkBa, COX-2,
NOX-4, pIKKa/b, MSK1, pMSK1, p50 and p65. Blots were
washed three times with PBST or TBST at 5 min intervals followed
by incubation with 1:5000 dilution of respective horseradish
peroxidase (HRP) conjugated secondary antibodies (rabbit, goat
or mouse) in 3% fat-free dry milk-PBST for 1 h at room
temperature. The blots were rinsed again three times with PBST
or TBST. The immunoblots were visualized with an ECL detection
kit according to the manufacturer’s instructions.
Immunohistochemical analysis
The dissected mouse skin from different treatment groups was
prepared for immunohistochemical analysis of the expression of
COX-2 and phospho-MSK1 (threonine 581). Four-micrometer
sections of 10% formalin-fixed, paraffin-embedded tissues were cut
on salinized glass slides and deparaffinized three times with xylene,
and rehydrated through graded alcohol bath. The deparaffinized
sections were heated with microwave and boiled twice for 6 min in
10 mM citrate buffer (pH 6.0) for antigen retrieval. To diminish
non-specific staining, each section was treated with 3% hydrogen
peroxide and 4% peptone casein blocking solution for 15 min. For
the detection of respective protein expression, slides were
incubated with affinity purified rabbit polyclonal anti-COX-2
and anti-pMSK1 (threonine 581) (1:50) at room temperature for
40 min in Tris-buffered saline containing 0.05% Tween 20 and
then developed using anti-rabbit HRP EnVision
TM System (Dako,
Glostrup, Denmark). The peroxidase binding sites were detected
by staining with 3,39-diaminobenzidine tetrahydrochloride (Dako,
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Mayer’s hematoxylin.
Preparation of cytosolic and nuclear extracts
The cytosolic and nuclear extract from mouse skin was
prepared as described previously [19]. In brief, scraped dorsal
skin of mice was homogenized in 800 ml of hypotonic buffer A
[10 mM HEPES (pH 7.8), 10 mM KCl, 2 mM MgCl2,1m M
dithiothreitol, 0.1 mM EDTA, 0.1 mM phenylmethylsulfonyl-
fluoride (PMSF)]. To the homogenates was added 80 ml of 10%
Nonidet P-40 (NP-40) solution, and the mixture was then
centrifuged for 2 min at 14,000 x g. The supernatant was collected
as cytosolic fraction. The precipitated nuclei were washed once
with 500 ml of buffer A plus 40 ml of 10% NP-40, centrifuged,
resuspended in 200 ml of buffer C [50 mM HEPES (pH 7.8),
50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM dithiothre-
itol, 0.1 mM PMSF, 20% glycerol] and centrifuged for 5 min at
14,800 x g. The supernatant containing nuclear proteins was
collected and stored at 270uC after determination of protein
concentration.
Electrophoretic mobility shift assay (EMSA)
The EMSA for DNA binding of NF-kB was performed using a
DNA-protein binding detection kit (Gibco BRL, Grand Island,
NY, USA), according to the manufacturer’s protocol. Briefly,
oligonucleotide harboring the binding site for NF-kB( 5 9–
GATCGAGGGGGACTTTCCCAGC- 39) was labeled with
[c-
32P]ATP by T4 polynucleotide kinase (Takara Bio Inc., Shiga,
Japan) and purified on a Nick column (Amersham Pharmacia
Biotech, USA). The binding reaction was carried out in 25 mlo f
mixture containing 5 ml of incubation buffer [10 mM Tris-HCl
(pH 7.5), 100 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, 4%
glycerol, and 0.1 mg/ml sonicated salmon sperm DNA], 10 mgo f
nuclear extracts, and 100000 cpm of [c-
32P]ATP-end labeled
oligonucleotide. After 50 min incubation at room temperature,
2 ml of 0.1% bromophenol blue was added, and samples were
electrophoresed through 6% nondenaturing polyacrylamide gel at
150 V in a cold room for 2 h. To ensure the specificity of the
binding, a competition assay was carried out with the excess
unlabeled oligonucleotide. Finally, the gel was dried and exposed
to an X-ray film.
Statistical analysis
Values were expressed as the mean 6 SEM of at least three
independent experiments. Statistical significance was determined
by Student’s t test and a p-value of less than 0.05 was considered to
be statistically significant.
Supporting Information
FigureS1 StatisticalanalysisofdatapresentedinFig.3A,
3B, 3C, 3E, 3F and 3G. Band intensity of immunoblots obtained
from threemiceinatreatmentgroup wassubjected todensitometric
analysis by using GelPro 3.0 and a ratio of band intensity of
respective immunoblots to that of internal standard actin or Lamin
B was calculated. Statistical analysis was performed using SigmaPlot
2001 to determine the level of significance. (Figure S1A) time-
dependent expression of pMSK1 in UVB-irradiated mouse skin. *,
p,0.001 (control versus UVB). (Figure S1B) Inhibitory effect of H-
89 on UVB-induced phosphorylation of MSK1 in mouse skin. *,
p,0.001 (control versus UVB); **, p,0.001 (UVB versus 25 nmol
H-89 plus UVB); ***, p,0.01 (UVB versus 100 nmol H-89 plus
UVB). (Figure S1C) pretreatment with DHA attenuated UVB-
induced phosphorylation of MSK1 in mouse skin. *, p,0.001
(control versus UVB); **, p,0.05 (UVB versus 10 mmol DHA plus
UVB). (Figure S1D) Kinetics of UVB-induced phosphorylation of
ERK and p38 MAP kinase in mouse skin. *, p,0.001 (control
versus UVB). (Figure S1E) Inhibitory effects of DHA on UVB-
induced phosphorylation of ERK and p38 MAP kinase. *, p,0.001
(control versus UVB); **, p,0.05 (UVB versus 2.5 mmol DHA plus
UVB); ***, p,0.001 (UVB versus 10 mmol DHA plus UVB).
(Figure S1F) Effect of H-89 on UVB-induced phosphorylation of
ERK and p38 MAP kinase. *, p,0.001 (control versus UVB alone).
(TIF)
Figure S2 Effect of H-89 on UVB-induced phosphoryla-
tion of IKKa/b in mouse skin. Topical application of H-89
(25 nmol) failed to alter UVB-induced phosphorylation of IKKa/
b in mouse skin.
(TIF)
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